Cite

HARVARD Citation

    Bloor, A. et al. (n.d.). Survival outcomes and treatment costs for patients with double‐refractory chronic lymphocytic leukaemia (DR‐CLL). British journal of haematology. pp. 449-452. [Online]. 
  
Back to record